medical device
The company has entered into a collaboration to develop a care monitoring platform.
Silicon Valley Bank report predicts VCs will slow down their deal pace in 2022.
The fund seeks to capitalise on Europe’s rapidly expanding digital health landscape.
The medical device company has signed an MoU with DHI 2048 to deploy 2,500 systems to the region by the year 2025.
Also, Genesis MedTech closes Series B funding round.
The yet-to-be-named programme reportedly “leverages machine learning to optimise a clinical trial’s chances of success” through the analysis of factors such as patient population recruitment and dropout rate.
Investment proceeds will primarily fund FDA registration studies and opening of US headquarters.
They signed deals with MaQuestionMedicale in France and HomeDoctor in Spain.
The new office will support the firm’s plans for advanced injection, wearable devices and connected health technologies.
This morning, the FDA published its 17-page first draft of a working model for its pre-certification program for software as a medical device (SaMD).